| DFSVX | HTSCX | DFSVX / HTSCX | |
| Total Expense Ratio | 0.31 | 2.06 | 15% |
| Annual Report Gross Expense Ratio | 0.31 | 2.10 | 15% |
| Fund Existence | 33 years | 22 years | - |
| Gain YTD | 21.336 | 22.166 | 96% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 19.5B | 305M | 6,393% |
| Annual Yield % from dividends | 1.50 | 0.13 | 1,172% |
| Returns for 1 year | 34.39 | 23.73 | 145% |
| Returns for 3 years | 50.37 | 29.23 | 172% |
| Returns for 5 years | 50.66 | 8.22 | 616% |
| Returns for 10 years | 107.71 | 15.96 | 675% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HSVRX | 54.68 | 0.40 | +0.74% |
| Harbor Small Cap Value Admin | |||
| DESSX | 29.04 | 0.10 | +0.35% |
| DWS Enhanced Core Equity S | |||
| AGIRX | 22.31 | 0.05 | +0.22% |
| Alger Mid Cap Growth Institutional R | |||
| IAXSX | 9.86 | -0.03 | -0.30% |
| VY® T. Rowe Price Divers Mid Cap Gr S | |||
| THISX | 89.95 | -1.09 | -1.20% |
| T. Rowe Price Health Sciences I | |||